Cargando…

Absence of altered expression of optineurin in primary open angle glaucoma patients

PURPOSE: To investigate the expression level of the optineurin gene (OPTN) in the blood of primary open angle glaucoma (POAG) patients to determine if altered expression is playing a role in primary open angle glaucoma systemically. METHODS: Patients (n=47) were eligible for inclusion if they met st...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Amero, Khaled K., Azad, Taif Anwar, Spaeth, George L., Myers, Jonathan, Katz, L. Jay, Moster, Marlene, Bosley, Thomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370688/
https://www.ncbi.nlm.nih.gov/pubmed/22690120
_version_ 1782235147023679488
author Abu-Amero, Khaled K.
Azad, Taif Anwar
Spaeth, George L.
Myers, Jonathan
Katz, L. Jay
Moster, Marlene
Bosley, Thomas M.
author_facet Abu-Amero, Khaled K.
Azad, Taif Anwar
Spaeth, George L.
Myers, Jonathan
Katz, L. Jay
Moster, Marlene
Bosley, Thomas M.
author_sort Abu-Amero, Khaled K.
collection PubMed
description PURPOSE: To investigate the expression level of the optineurin gene (OPTN) in the blood of primary open angle glaucoma (POAG) patients to determine if altered expression is playing a role in primary open angle glaucoma systemically. METHODS: Patients (n=47) were eligible for inclusion if they met standard clinical criteria for POAG, including age greater than 40 years, intraocular pressure ≥21 mmHg in at least one eye before treatment, normal-appearing anterior chamber angles bilaterally on gonioscopy, and optic nerve injury characteristic of POAG. Control subjects (n=27) were recruited who were free from glaucoma by examination. DNA from patient was sequenced to look for possible mutations in the coding region of OPTN or its promoter. RNA was extracted from leukocytes of patients and controls and converted to cDNA by reverse transcriptase enzyme, and quantitative PCR was used to assess expression levels of OPTN and the β-globulin gene. The ratio of OPTN expression to β-globulin gene expression for POAG patients was compared to that of controls and to clinical characteristics of POAG patients. RESULTS: No mutation(s) were detected in any of the patients after sequencing the full OPTN gene and its promoter region. Mean OPTN (p≤0.35), and β-globulin (p≤0.48) gene expression values were statistically similar in POAG patients and controls. OPTN/β-globulin (p≤0.83) ratios were also indistinguishable between POAG patients and controls. OPTN/β-globulin ratios were not significantly associated with age, sex, or ethnicity of patients within the POAG group. Similarly, OPTN/β-globulin ratios were not significantly affected by ethnicity or clinical parameters related to POAG severity including maximum intraocular pressure, vertical cup-to-disk ratio, static perimetry mean deviation, or static perimetry pattern standard deviation. CONCLUSIONS: OPTN expression is not altered in the blood of POAG patients, suggesting that OPTN expression is not changed systemically and implying that other mechanisms are involved in POAG pathogenesis.
format Online
Article
Text
id pubmed-3370688
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-33706882012-06-11 Absence of altered expression of optineurin in primary open angle glaucoma patients Abu-Amero, Khaled K. Azad, Taif Anwar Spaeth, George L. Myers, Jonathan Katz, L. Jay Moster, Marlene Bosley, Thomas M. Mol Vis Research Article PURPOSE: To investigate the expression level of the optineurin gene (OPTN) in the blood of primary open angle glaucoma (POAG) patients to determine if altered expression is playing a role in primary open angle glaucoma systemically. METHODS: Patients (n=47) were eligible for inclusion if they met standard clinical criteria for POAG, including age greater than 40 years, intraocular pressure ≥21 mmHg in at least one eye before treatment, normal-appearing anterior chamber angles bilaterally on gonioscopy, and optic nerve injury characteristic of POAG. Control subjects (n=27) were recruited who were free from glaucoma by examination. DNA from patient was sequenced to look for possible mutations in the coding region of OPTN or its promoter. RNA was extracted from leukocytes of patients and controls and converted to cDNA by reverse transcriptase enzyme, and quantitative PCR was used to assess expression levels of OPTN and the β-globulin gene. The ratio of OPTN expression to β-globulin gene expression for POAG patients was compared to that of controls and to clinical characteristics of POAG patients. RESULTS: No mutation(s) were detected in any of the patients after sequencing the full OPTN gene and its promoter region. Mean OPTN (p≤0.35), and β-globulin (p≤0.48) gene expression values were statistically similar in POAG patients and controls. OPTN/β-globulin (p≤0.83) ratios were also indistinguishable between POAG patients and controls. OPTN/β-globulin ratios were not significantly associated with age, sex, or ethnicity of patients within the POAG group. Similarly, OPTN/β-globulin ratios were not significantly affected by ethnicity or clinical parameters related to POAG severity including maximum intraocular pressure, vertical cup-to-disk ratio, static perimetry mean deviation, or static perimetry pattern standard deviation. CONCLUSIONS: OPTN expression is not altered in the blood of POAG patients, suggesting that OPTN expression is not changed systemically and implying that other mechanisms are involved in POAG pathogenesis. Molecular Vision 2012-06-01 /pmc/articles/PMC3370688/ /pubmed/22690120 Text en Copyright © 2012 Molecular Vision. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Abu-Amero, Khaled K.
Azad, Taif Anwar
Spaeth, George L.
Myers, Jonathan
Katz, L. Jay
Moster, Marlene
Bosley, Thomas M.
Absence of altered expression of optineurin in primary open angle glaucoma patients
title Absence of altered expression of optineurin in primary open angle glaucoma patients
title_full Absence of altered expression of optineurin in primary open angle glaucoma patients
title_fullStr Absence of altered expression of optineurin in primary open angle glaucoma patients
title_full_unstemmed Absence of altered expression of optineurin in primary open angle glaucoma patients
title_short Absence of altered expression of optineurin in primary open angle glaucoma patients
title_sort absence of altered expression of optineurin in primary open angle glaucoma patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370688/
https://www.ncbi.nlm.nih.gov/pubmed/22690120
work_keys_str_mv AT abuamerokhaledk absenceofalteredexpressionofoptineurininprimaryopenangleglaucomapatients
AT azadtaifanwar absenceofalteredexpressionofoptineurininprimaryopenangleglaucomapatients
AT spaethgeorgel absenceofalteredexpressionofoptineurininprimaryopenangleglaucomapatients
AT myersjonathan absenceofalteredexpressionofoptineurininprimaryopenangleglaucomapatients
AT katzljay absenceofalteredexpressionofoptineurininprimaryopenangleglaucomapatients
AT mostermarlene absenceofalteredexpressionofoptineurininprimaryopenangleglaucomapatients
AT bosleythomasm absenceofalteredexpressionofoptineurininprimaryopenangleglaucomapatients